| Literature DB >> 34296492 |
Ting Su1,2, Jiaying Gong2,3, Guixian Tang1,2, Shaojuan Qiu1, Pan Chen1,2, Guanmao Chen1,2, Junjing Wang4, Li Huang1, Ying Wang1.
Abstract
Anorexia nervosa (AN) is a complex psychiatric disorder with poorly understood etiology. Numerous voxel-based morphometry (VBM) and resting-state functional imaging studies have provided strong evidence of abnormal brain structure and intrinsic and functional activities in AN, but with inconsistent conclusions. Herein, a whole-brain meta-analysis was conducted on VBM (660 patients with AN, and 740 controls) and resting-state functional imaging (425 patients with AN, and 461 controls) studies that measured differences in the gray matter volume (GMV) and intrinsic functional activity between patients with AN and healthy controls (HCs). Overall, patients with AN displayed decreased GMV in the bilateral median cingulate cortex (extending to the bilateral anterior and posterior cingulate cortex), and left middle occipital gyrus (extending to the left inferior parietal lobe). In resting-state functional imaging studies, patients with AN displayed decreased resting-state functional activity in the bilateral anterior cingulate cortex and bilateral median cingulate cortex, and increased resting-state functional activity in the right parahippocampal gyrus. This multimodal meta-analysis identified reductions of gray matter and functional activity in the anterior and median cingulate in patients with AN, which contributes to further understanding of the pathophysiology of AN.Entities:
Keywords: anorexia nervosa; meta-analysis; multimodal; resting-state functional imaging; voxel-based morphometry
Mesh:
Year: 2021 PMID: 34296492 PMCID: PMC8449099 DOI: 10.1002/hbm.25602
Source DB: PubMed Journal: Hum Brain Mapp ISSN: 1065-9471 Impact factor: 5.038
FIGURE 1Flow chart of meta‐analysis of voxel‐based morphometry (VBM) and resting‐state functional imaging studies of patients with anorexia nervosa (AN)
Demographic, clinical, and imaging characteristics of the included studies of VBM
| Study | Demographic characteristics | Clinical characteristics (AN patients) | Imaging characteristics | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Participants (female), | Mean age ± | Age group | AN state | Comorbid | Illness duration (months) | Age at onset (years) | BMI | Scanner | Software | FWHM (mm) | Threshold | Quality score | ||||
| AN | HC | AN | HC | AN | HC | |||||||||||
| (Wagner et al., 2006) | 14(14) | 31(31) | 23.7±5.3 | 26.8±7.3 | Adult | Recovered | NO | 28.7±20.4 | 18.2±4.5 | 21.2±2.0 | 21.9±2.0 | 1.5T MRI | SPM2 | 12 | 10 | |
| 16(16) | 27.4±7.2 | Adult | Recovered | NO | 39.5±52.7 | 15.7±2.7 | 21.2±1.5 | NA | ||||||||
| (Muhlau et al., 2007) | 22(22) | 37(37) | 27.2 | 27.4 | Adult | Recovered | NO | 116 | 17.6 | 19.8 | 21.1 | 1.5 T MRI | SPM2 | 14 | 10 | |
| (Castro‐Fornieles et al., 2009) | 12(11) | 9(8) | 14.5±1.5 | 14.6±3.2 | Adolescent | NA | NO | NA | NA | 14.8±2.0 | NA | 1.5 T MRI | SPM5, FSL | NA | 9 | |
| (Suchan et al., | 13(13) | 14(14) | 26.8±8.4 | 29.5±8.2 | Adult | Chronic | NO | 66.0±60.0 | NA | 16.0±1.3 | 22.0±2.1 | 1.5 T MRI | SPM5 | 12 | 9.5 | |
| (Boghi et al., 2011) | 21(21) | 27(27) | 29.0±10.0 | 30.8±8.7 | Adult | Recovered/acute | NO | 135.6±145.2 | NA | 15.5±1.8 | 21.9±1.5 | 1.0 T MRI | SPM2 | 12 | PFDR <.05 | 9.5 |
| 10(10) | 13(13) | 21.4±2.5 | 22.8±1.5 | Adult | Acute | NO | 22.8±15.6 | NA | 15.0±1.2 | 21.7±1.7 | NA | NA | NA | |||
| 11(11) | 14(14) | 35.9±9.25 | 38.2±5.1 | Adult | Chronic | NO | 237.6±133.2 | NA | 16.0±2.1 | 22.1±1.4 | 1.0 T MRI | NA | ||||
| (Brooks et al., | 14(14) | 21(21) | 26.0±1.9 | 26±2.1 | Adult | NA | YES | 110.4±22.8 | NA | 15.6±0.4 | 21.4±0.5 | 1.5 T MRI | SPM5 | 12 | NA | 9.5 |
| (Gaudio et al., 2011) | 16(16) | 16(16) | 15.2±1.7 | 15.1±1.5 | Adolescent | Acute | NO | 5.3±3.2 | 14.7±1.7 | 14.2±1.4 | 20.2±1.6 | 1.5 T MRI | SPM2 | NA | 10 | |
| (Joos et al., 2011) | 5(5) | 18(18) | 29.6±5.1 | 26.9±5.7 | Adult | Recovered | NO | 86.4±72 | NA | 19.9±1.5 | 21.2±2.0 | 3.0 T MRI | SPM8 | 12 | 9 | |
| 12(12) | 25.0±4.8 | Adult | NO | NA | NA | 16.0±1.2 | 21.2±2.0 | |||||||||
| (Friederich et al., 2012) | 12(12) | 14(14) | 24.3±6.2 | 25.6±3.7 | Adult | Acute | NO | 75.6±52.8 | NA | 15.9±1.6 | 21.1±1.5 | 3.0 T MRI | SPM5 | 8 | 9 | |
| 13(13) | 25.0±4.8 | Adult | Recovered | NO | 68.4±43.2 | NA | 19.5±1.4 | 21.1±1.5 | ||||||||
| (Mainz et al., | 19(19) | 19(19) | 15.7±1.5 | 15.6±1.9 | Adolescent | Recovered | YES | NA | NA | 15.3±1.5 | 21.8±2.7 | 3.0 T MRI | SPM5 | NA | FWE corrected | 9.5 |
| (Amianto et al., | 17(17) | 14(14) | 20.0±4.0 | 24.0±3.0 | Adolescent | Acute | NO | 13.0±8.0 | NA | 16.0±1.0 | 21±2 | 1.5 T MRI | FSL | 7 | 9.5 | |
| (Cicerale et al., | 10(10) | 8(8) | 22.0±4.0 | 24.0±2.0 | Adult | NA | NA | 16.0±9.0 | 16±9 | 15.9±1.0 | 21.1±1.7 | 1.5 T MRI | FSL | 7 | 9 | |
| (Frank, Shott, Hagman, & Mittal, 2013) | 19(19) | 24(24) | 23.1±5.8 | 27.4±6.3 | Adult | Acute | NO | NA | NA | 16.0±1.1 | 21.6±1.3 | 3.0 T MRI | SPM8 | 8 | 9.5 | |
| (Lazaro et al., | 35(NA) | 17(NA) | 16.3±1.3 | 16.7±1.5 | Adolescent | Recovered | NO | 7.4±5.2 | 14.02±1.6 | 19.3±1.1 | NA | 1.5 T MRI | SPM8 | 12 | 9 | |
| (Fonville, Giampietro, Williams, Simmons, & Tchanturia, 2014) | 31(NA) | 31(NA) | 23.0 | 25.0 | Adult | NA | YES | 84.0±120.0 | 16±4.75 | 15.8±1.4 | 21.8±1.8 | 1.5 T MRI | FSL | 7 | 9 | |
| (Bar, de la Cruz, Berger, Schultz, & Wagner, 2015) | 26(23) | 26(23) | 23.0±5.0 | 24.0±1.9 | NA | Acute | NO | 22.4±14.8 | NA | 17.0±1.5 | 21.7±1.5 | 1.5 T MRI | SPM8 | 10 | 9.5 | |
| (Bomba et al., 2015) | 11(11) | 8(8) | 13.6±2.8 | 13.3±2.4 | Adolescent | NA | NO | 14.5±10.9 | NA | 12.8±0.8 | 19.9±1.5 | 1.5 T MRI | SPM5 | 8 | 9 | |
| (D'Agata et al., 2015) | 21(21) | 17(17) | 21.0±5.0 | 23.0±4.0 | Adolescent | Acute | NO | NA | NA | 16.1±0.9 | 21.5±2.3 | 1.5 T MRI | FSL | NA | 9.5 | |
| (Fujisawa et al., 2015) | 20(20) | 14(14) | 14.2±1.8 | 14.9±1.6 | Adolescent | NA | NO | 23.6±17.0 | 12.6±1.8 | 14.4±2.1 | NA | 3.0 T MRI | SPM8 | 12 | L_IFG: | 9.5 |
| (Seitz et al., | 56(56) | 50(50) | 15.5±1.7 | 15.8±1.7 | Adolescent | Acute | NO | 11.4±8.3 | 14.5±1.6 | 15.1±1.4 | 21.4±3.3 | 3.0 T MRI | Free surfer | NA | 9.5 | |
| (van Opstal et al., 2015) | 10(10) | 11(11) | 22.1±3.3 | 20.8±0.5 | Adult | NA | NO | 42.5±27.6 | NA | 15.6±1.0 | 20.3±1.5 | 3.0 T MRI | FSL | NA | NA | 9 |
| (Björnsdotter et al., 2017) | 25(25) | 25(25) | 20.3±2.2 | 21.3±2.1 | Adolescent | NA | NO | 49.7±42.5 | NA | 16.3±0.9 | 21.1±2.3 | 3.0 T MRI | SPM8 | 8 | 9.5 | |
| (Kohmura et al., 2017) | 23(23) | 29(29) | 28.5±6.7 | 28.2±7.0 | Adult | NA | NO | 126±74.4 | 18.0±3.2 | 13.2±1.5 | 21.5±3.3 | 3.0 T MRI | SPM8 | 8 | 9.5 | |
| 23(23) | NA | NA | Adult | NA | NO | |||||||||||
| (Martin Monzon et al., 2017) | 26(26) | 20(20) | 16.5±0.3 | 17.3±0.4 | Adolescent | NA | NO | NA | NA | 16.7±0.2 | 22.6±0.9 | 3.0 T MRI | SPM12 | 6 | 9.5 | |
| (Nickel et al., | 34(34) | 41(41) | 23.8±4.3 | 23.6±3.8 | Adult | Acute | NO | 79.2±44.4 | NA | 16.1±1.4 | 22.3±2.4 | 3.0 T MRI | SPM12 | 8 | 9.5 | |
| (Olivo et al., 2018) | 22(22) | 38(38) | 14.9±1.6 | 14.7±1.3 | Adolescent | Acute | NO | 7.9±4.8 | NA | 19.3±2.0 | 20.7±2.3 | 3.0 T MRI | SPM12 | 8 | 9.5 | |
| (Phillipou et al., 2018) | 26(26) | 27(27) | 22.8±6.7 | 22.5±3.2 | Adolescent | Acute | YES | 6.4±7.4 | 16.0±3.4 | 16.6±1.2 | 22.6±3.5 | 3.0 T MRI | SPM12 | 8 | 9.5 | |
| (Oliva et al., | 15(15) | 15(15) | 25.9±6.2 | 25.2±1.0 | Adult | Recovered | NO | 38.4±38.0 | 16.5±2.3 | 20.1±2.0 | 21.3±2.5 | 1.5 T MRI | SPM12 | 8 | NA | 9.5 |
Abbreviations: AN, anorexia nervosa patients; BMI, body mass index; c, the Threshold‐Free Cluster Enhancement; FDR, false discovery rate; FSL, FMRIB's Software Library, the University of Oxford; FWE, family wise error; FWHM, full width at half maximum; HC, healthy control; IFG, inferior frontal gyrus; L_IFG, left IFG; NA, not available; R_IFG, right IFG; SPM, statistical parametric mapping; VBM, voxel‐based morphometry.
Total score out of 10.
At least two data sets are included.
Demographic, clinical, and imaging characteristics of the included studies of resting‐state functional activity
| Study | Demographic characteristics | Clinical characteristics (AN patients) | Imaging characteristics | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Participants (female), | Mean age± | Age group | AN state | Comorbid | Illness duration (months) | Age at onset (years) | BMI | Imaging technique | Scanner | Software | FWHM (mm) | Threshold | Quality score | ||||
| AN | HC | AN | HC | AN | HC | ||||||||||||
| (Gordon et al., | 8(8) | 8(8) | 20.1±2.6 | 23.7±2.6 | NA | NA | NO | 33.2±32.4 | NA | 18.0±3.5 | 21.7±1.8 |
| PET | SPM96 | 6 | NA | 8.5 |
| (Naruo et al., | 7(7) | 7(7) | NA | NA | NA | NA | NO | NA | NA | 12.8±2.1 | 20.0±1.4 |
| SPECT | SPM96 | 12 | NA | 8.5 |
| (Takano et al., | 14(14) | 8(8) | 21.2±6.6 | 28.3±3.3 | NA | NA | NO | 16.8±9.6 | NA | 14.0±2.2 | 19.7±0.8 |
| SPECT | SPM96 | 10 | 9 | |
| (Kojima et al., | 12(12) | 11(11) | 18.6±3.5 | 21.8±2.1 | NA | Before WG | NO | NA | NA | 12.5±1.7 | 20.1±0.8 |
| SPECT | SPM99 | 12 | 9.5 | |
| 12(12) | 11(11) | 18.8±3.5 | 21.8±2.1 | NA | After WG | NO | NA | NA | 15.6±0.7 | 20.1±0.8 | NA | NA | |||||
| (Jinjue et al., | 3(3) | 25(25) | 20.3 | 20.4±1.8 | Adult | NA | NO | NA | NA | 16.3 | 21.3±1.2 |
| SPECT | SPM2 | NA | 9 | |
| (Yonezawa et al., | 26(26) | 10(10) | 22.2±3.9 | 20.6±1.7 | NA | Acute and chronic | NO | 32.0±22.4 | 19.7±4.3 | 13.5±1.3 | 19.7 ±1.8 |
| SPECT | NA | 8 | NA | 9.5 |
| 13(13) | 10(10) | 22.2±3.6 | 20.6±1.7 | NA | Acute | NO | 30.3±23.7 | 19.6±4.6 | 13.8±1.5 | 19.7 ±1.8 | NA | NA | NA | ||||
| 13(13) | 10(10) | 22.3±4.4 | 20.6±1.7 | NA | Chronic | NO | 33.8±21.9 | 19.7±4.2 | 13.4±1.2 | 19.7 ±1.8 | NA | NA | NA | ||||
| (Cicerale et al., | 10(10) | 8(8) | 22.0±4.0 | 24.0±2.0 | NA | NA | NO | 16.0±9.0 | 20.0±4.0 | 15.9±1.0 | 21.1 ±1.7 |
| 1.5T MRI | FSL | NA | 9.0 | |
| (Pasanisi et al., | 7(7) | 20(20) | 23.4±4.5 | 25.6±3.9 | Adult | Acute | NO | NA | NA | 15.5±0.8 | 22.2±1.5 |
| PET | NA | NA | NA | 8.5 |
| 3(3) | 20(20) | 21.3±1.5 | 25.6±3.9 | NA | Recovered | NO | NA | NA | 18.8±1.1 | 22.2±1.5 | NA | NA | NA | ||||
| (Yue, | 8(8) | 8(8) | 20.2±4.8 | 19.7±3.5 | 14‐32 | NA | NO | NA | NA | 16.1±2.8 | 20.6±2.4 |
| 3.0T MRI | SPM8 | 4 | 8.5 | |
| (Zhang et al., | 6(6) | 12(12) | 17.0±0.8 | 24.0±3.3 | NA | NA | NO | 23.8±10.5 | NA | 12.2±1.0 | NA |
| PET | SPM2 | 10 | 9.0 | |
| (Sheng et al., | 23(23) | 25(25) | 25.8±8.3 | 25.5±6.6 | Adult | Acute | YES | NA | NA | 18.2±1.6 | 22.6±2.7 |
| 3.0T MRI | SPM5 | 8 | 9.5 | |
| 19(19) | 25(25) | 30.4±8.4 | 25.5±6.6 | Adult | Recovered | YES | NA | NA | 23.0±3.0 | 22.6±2.7 | |||||||
| (Wierenga et al., | 21(21) | 16(16) | 27.2±1.7 | 23.9±1.5 | Adult | NA | NO | NA | NA | 21.8±0.3 | 22.4±0.4 |
| 3.0T MRI | FSL | 4 | 9.5 | |
| (Seidel et al., | 74(74) | 74(74) | 16.0±2.9 | 16.2±2.9 | 12.1‐28.5 | Acute and nonchronic | NO | 17.5±22.7 | NA | 14.6±1.3 | 20.6±2.6 |
| 3.0T MRI | SPM8 | 6 | 9.5 | |
| 74(74) | 74(74) | 16.0±2.9 | 16.2±2.9 | NA | NO | 14.5±1.3 | 20.6±2.6 |
| 3.0T MRI | NA | NA | NA | |||||
| (Lai et al., | 7(7) | 14(14) | 17.5±2.4 | 19.1±3.1 | NA | Acute | NO | 10.3±6.7 | NA | 13.7±1.4 | 19.6±1.8 |
| 3.0T MRI | DPARSF | 4 | 9 | |
| (Seidel et al., | 65(65) | 65(65) | 22.06±3.3 | 22.05±3.3 | NA | Recovered | NO | NA | NA | 20.7±1.8 | 21.61±2 |
| 3.0T MRI | SPM8 | 6 | 9.5 | |
Abbreviations: ALFF, amplitude of low‐frequency fluctuation; AN, anorexia nervosa patients; ASL, arterial Spin Labeling; BMI, body mass index; DPARSF, data processing assistant for resting‐State fMRI software; fALFF, the fractional ALFF; FDR, false discovery rate; fMRI, functional magnetic resonance imaging; FSL, FMRIB's Software Library, the University of Oxford; FWE, family wise error; FWHM, full width at half maximum; HC, healthy control; NA, not available; ReHo, regional homogeneity; SD, standard deviation; SPM, statistical parametric mapping; TFCE, the threshold‐free cluster enhancement; WG, weight gain.
Include ALFF, ALFF, ReHo, PET, SPECT, and ASL.
Total score out of 10.
Represents at least two data sets are included.
Meta‐analyses results regarding VBM and resting‐state functional brain activity difference between AN and HCs
| Local maximum | Cluster | |||||||
|---|---|---|---|---|---|---|---|---|
| Region | Peak MNI coordinate (x, y, z) | SDM‐Z value | No. of voxels | Breakdown (no. of voxels) | Egger's test ( | Jackknife sensitivity | Heterogeneity | |
|
| ||||||||
| 0,−30,40 | −4.727 | .001 | 5497 |
Left precuneus, BA 5 (860) Right precuneus, BA 7 (503) Left anterior cingulate/paracingulate gyri, BA 32 (434) | .906 | 35/35 | No ( | |
| Right anterior cingulate/paracingulate gyri, BA 32 (225) | ||||||||
| Left median cingulate/paracingulate gyri, BA 24 (1141) | ||||||||
| Right median cingulate/paracingulate gyri, BA 4 (1046) | ||||||||
| Left posterior cingulate gyrus, BA 26 (272) | ||||||||
| Right posterior cingulate gyrus, BA 26 (72) | ||||||||
| Left superior frontal gyrus, medial (168) | ||||||||
| Right superior frontal gyrus, medial (17) | ||||||||
| Left middle occipital gyrus, BA 7 | −32,−72,38 | −3.425 | .027 | 124 | Left inferior parietal gyri, BA 7 (36) | .982 | 35/35 | No ( |
| Left middle occipital gyrus, BA 7 (49) | ||||||||
| Left superior occipital gyrus, BA 7 (15) | ||||||||
| Left superior parietal gyrus, BA 7 (9) | ||||||||
|
| ||||||||
| 24,2,‐32 | 1.905 | <.001 | 465 |
Right temporal pole, middle temporal gyrus, BA 36 (78) Right parahippocampal gyrus, BA 28 (106) Right amygdala, BA 36 (94) | .979 | 22/22 | No ( | |
| 0,36,20 | −1.705 | <.001 | 1317 |
Left anterior cingulate/paracingulate gyri, BA 32 (595) Right anterior cingulate/paracingulate gyri, BA 32 (235) Left median cingulate/paracingulate gyri, BA 24 (150) Right median cingulate/paracingulate gyri, BA 24 (99) | .084 | 19/22 | No ( | |
Abbreviations: AN, anorexia nervosa; BA, Brodmann area; HCs, healthy controls; JK, Jackknife sensitivity analysis; MNI, Montreal Neurological Institute; SDM, the seed‐based d mapping; VBM, voxel‐based morphometry.
FIGURE 2Meta‐analyses results regarding (a) GMV difference between AN and HCs, (b) Resting‐state functional activity difference between AN and HCs, (c) Conjunction of GMV differences and resting‐state functional activity differences. Areas with decreased GMV value or resting‐state functional activity value are displayed in blue, and areas with increased GMV value or resting‐state functional activity value are displayed in red. The color bar indicates the maximum and minimum SDM‐Z values. AN, anorexia nervosa; HCs, healthy controls; SDM, seed‐based d mapping; VBM, voxel‐based morphometry; GMV, gray matter volume